Full Text | PDF

Share on tweeters Share on facebook Share on linkedin Share on googleplus

Int J Biol Sci 2021; 17(1):271-284. doi:10.7150/ijbs.50003 This issue Cite

Review

The emerging roles of m6A modification in liver carcinogenesis

Xue-yin Pan1,2,3, Cheng Huang1,2,3, Jun Li1,2,3✉

1. Inflammation and Immune Mediated Diseases Laboratory of Anhui Province, Anhui Institute of Innovative Drugs, School of Pharmacy, Anhui Medical University, Hefei, 230032, China.
2. The Key Laboratory of Anti-inflammatory of Immune Medicines, Ministry of Education.
3. Institute for Liver Diseases of Anhui Medical University.

✉ Corresponding author: Li Jun, Professor of Pharmacology, School of Pharmacy, Anhui Medical University. Hefei, Anhui, China. Tel.: +86-551-65167230; Fax: +86-551-65167230; E-mail: ljedu.cn.

Citation:
Pan Xy, Huang C, Li J. The emerging roles of m6A modification in liver carcinogenesis. Int J Biol Sci 2021; 17(1):271-284. doi:10.7150/ijbs.50003. https://www.ijbs.com/v17p0271.htm
Other styles

File import instruction

Abstract

Graphic abstract

The 'epitranscriptome', a collective term for chemical modifications that influence the structure, metabolism, and functions of RNA, has recently emerged as vitally important for the regulation of gene expression. N6-methyladenosine (m6A), the most prevalent mammalian mRNA internal modification, has been demonstrated to have a pivotal role in almost all vital bioprocesses, such as stem cell self-renewal and differentiation, heat shock or DNA damage response, tissue development, and maternal-to-zygotic transition. Hepatocellular carcinoma (HCC) is prevalent worldwide with high morbidity and mortality because of late diagnosis at an advanced stage and lack of effective treatment strategies. Epigenetic modifications including DNA methylation and histone modification have been demonstrated to be crucial for liver carcinogenesis. However, the role and underlying molecular mechanism of m6A in liver carcinogenesis are mostly unknown. In this review, we summarize recent advances in the m6A region and how these new findings remodel our understanding of m6A regulation of gene expression. We also describe the influence of m6A modification on liver carcinoma and lipid metabolism to instigate further investigations of the role of m6A in liver biological diseases and its potential application in the development of therapeutic strategies.

Keywords: Epitranscriptome, N6-methyladenosine, Hepatocellular Carcinoma (HCC)

Citation styles

APA
Pan, X.y., Huang, C., Li, J. (2021). The emerging roles of m6A modification in liver carcinogenesis. International Journal of Biological Sciences, 17(1), 271-284. https://doi.org/10.7150/ijbs.50003.

ACS
Pan, X.y.; Huang, C.; Li, J. The emerging roles of m6A modification in liver carcinogenesis. Int. J. Biol. Sci. 2021, 17 (1), 271-284. DOI: 10.7150/ijbs.50003.

NLM
Pan Xy, Huang C, Li J. The emerging roles of m6A modification in liver carcinogenesis. Int J Biol Sci 2021; 17(1):271-284. doi:10.7150/ijbs.50003. https://www.ijbs.com/v17p0271.htm

CSE
Pan Xy, Huang C, Li J. 2021. The emerging roles of m6A modification in liver carcinogenesis. Int J Biol Sci. 17(1):271-284.

This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions.
Popup Image

©2024 Ivyspring International Publisher. Terms of use